Strategy is only useful when it changes the decision.

Pharmamosaic is an independent pharma strategy consultancy for commercial, launch, access, medical, and business development teams facing decisions that do not fit a standard framework.

We sit on the commercial side of the pharma value chain: asset strategy, launch readiness, competitive intelligence, opportunity assessment, and organisational design. We do not do drug discovery, clinical development, or manufacturing strategy. We help teams make sharper commercial choices when the evidence is incomplete, the timeline is compressed, and the organisation needs to act.

Why Pharmamosaic Exists

Most strategic questions in pharma are not solved by a model alone.

A valuation can be technically sound and still fail if the assumptions are not credible. A launch plan can look complete and still fall apart if the affiliates, access team, medical team, and commercial team are not set up to execute it. A competitive landscape can be beautifully mapped and still avoid the decision leadership actually needs to make.

Pharmamosaic was built for the space between analysis and action.

We combine disciplined evidence, commercial judgment, and organisational thinking, so recommendations are not only clear on the page but usable on Monday morning.

Experience On Both Sides Of The Table

Pharmamosaic brings together experience from inside Big Pharma commercial and operations functions, alongside partner-level consulting work across vaccines, specialty, and rare disease.

That combination matters. The recommendations come from someone who has not only advised leadership teams, but also seen what happens when strategy meets operating reality: the trade-offs, the internal friction, the affiliate constraints, the access dependencies, and the implementation details that determine whether a plan holds.

How We Work

Every engagement starts with the decision.

Before building a model, running interviews, or mapping a market, we clarify the question that needs to be answered and the evidence that would genuinely change the answer. From there, the work stays focused: structured analysis, explicit assumptions, clear implications, and practical recommendations.

The goal is not to produce strategy that gets filed. The goal is to help teams decide, align, and move.

What Makes Us Different

Pharmamosaic brings four things to every engagement:

• Commercial specificity. We focus on the decisions that shape how an asset reaches the market and performs once it is there.

• Analytical discipline. Every recommendation is traceable to evidence, assumptions, and judgment calls that can be tested.

• Organisational realism. We look at what the team needs to deliver the strategy, not just what the strategy says.

• A working-partner model. The first conversation is a working session, not a sales process. You should leave with a clearer view of the problem, whether or not we work together.

If you are facing a commercial decision that does not fit a standard framework, bring us the question.
We will help you work out what evidence matters, what choices are really on the table, and what the organisation needs in order to act.